Artesunate Derivatives as Anticancer Agents: Hybrid Designs and Emerging Therapeutic Strategies
Milica Selaković,
Ljiljana Koračak,
Vladimir Ajdačić,
Andrea M. Nikolić,
Života Selaković,
Ana Andrijević,
Miguel Angel Merlos Rodrigo,
Igor M. Opsenica
Wiley ·
2026-11-17
· DOI 10.1002/cmdc.70577
The publisher did not provide an abstract — full text is available via the link below.
Milica Selaković, Ljiljana Koračak, Vladimir Ajdačić, Andrea M. Nikolić, Života Selaković, Ana Andrijević et al. Artesunate Derivatives as Anticancer Agents: Hybrid Designs and Emerging Therapeutic Strategies. // ChemMedChem. – 2026. – DOI: 10.1002/cmdc.70577. – URL: https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.70577?af=R
Milica Selaković, Ljiljana Koračak, Vladimir Ajdačić, Andrea M. Nikolić, Života Selaković, Ana Andrijević, Miguel Angel Merlos Rodrigo, & Igor M. Opsenica (2026). Artesunate Derivatives as Anticancer Agents: Hybrid Designs and Emerging Therapeutic Strategies. ChemMedChem. https://doi.org/10.1002/cmdc.70577
Milica Selaković, et al. “Artesunate Derivatives as Anticancer Agents: Hybrid Designs and Emerging Therapeutic Strategies.” ChemMedChem, 2026. doi:10.1002/cmdc.70577.
@article{Selakovi2026,
title = {Artesunate Derivatives as Anticancer Agents: Hybrid Designs and Emerging Therapeutic Strategies},
author = {Selaković, Milica and Koračak, Ljiljana and Ajdačić, Vladimir and Nikolić, Andrea M. and Selaković, Života and Andrijević, Ana and Rodrigo, Miguel Angel Merlos and Opsenica, Igor M.},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70577},
url = {https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.70577?af=R}
}